KO
46
5
ADI
76
-4
AIZ
59
-2
NTRS
64
-3
ABT
41
3
LB
42
-6
PM
58
4
STX
67
-7
FDX
53
-2
ED
39
3
EOG
49
-3
FLR
42
-4
PCAR
65
-3
CNX
52
-8
MNST
51
2
IRM
46
-11
MTCH
57
-2
EL
56
4
FE
50
-2
CPB
39
2
KO
46
5
ADI
76
-4
AIZ
59
-2
NTRS
64
-3
ABT
41
3
LB
42
-6
PM
58
4
STX
67
-7
FDX
53
-2
ED
39
3
EOG
49
-3
FLR
42
-4
PCAR
65
-3
CNX
52
-8
MNST
51
2
IRM
46
-11
MTCH
57
-2
EL
56
4
FE
50
-2
CPB
39
2
Financhill
Back

Lucid Group, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
14

LCID
Lucid Group, Inc.

Last Price:
$12.20
Seasonality Move:
13.86%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.14
Seasonality Move:
11.58%
Sell
14
Lucid Group, Inc. (LCID) is a Sell

Is Lucid Group, Inc. a Buy, Sell or Hold?

  • The current Lucid Group, Inc. [LCID] share price is $12.54. The Score for LCID is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • LCID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LCID Stock Price Chart

What is Lucid Group, Inc.'s stock price today?

  • The Lucid Group, Inc. share price today is $12.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LCID is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

LCID Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 37.46 Sell
Chaikin Money Flow: -5434716 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.11 - 15.31) Sell
Bollinger Bands (100): (15.21 - 23.49) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

LCID Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.09 Sell
20-day SMA: 12.98 Sell
50-day SMA: 16.74 Sell
200-day SMA: 21.55 Sell
8-day EMA: 12.91 Sell
20-day EMA: 13.63 Sell
50-day EMA: 15.94 Sell
200-day EMA: 21.34 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Lucid Group, Inc. Earnings Growth & LCID Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $3.11 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Lucid Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):